1. Home
  2. KTTA vs HUIZ Comparison

KTTA vs HUIZ Comparison

Compare KTTA & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.52

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

HOLD

Current Price

$1.42

Market Cap

16.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
HUIZ
Founded
2020
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
16.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
KTTA
HUIZ
Price
$0.52
$1.42
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$3.00
$2.30
AVG Volume (30 Days)
214.9K
1.4M
Earning Date
05-14-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
77.07
N/A
EPS
N/A
N/A
Revenue
$486,559.00
N/A
Revenue This Year
N/A
$8.58
Revenue Next Year
N/A
$6.64
P/E Ratio
N/A
$7.81
Revenue Growth
3130.37
N/A
52 Week Low
$0.28
$1.04
52 Week High
$2.06
$4.16

Technical Indicators

Market Signals
Indicator
KTTA
HUIZ
Relative Strength Index (RSI) 47.80 49.37
Support Level $0.48 $1.43
Resistance Level $0.52 $1.55
Average True Range (ATR) 0.04 0.10
MACD -0.01 -0.02
Stochastic Oscillator 34.21 18.03

Price Performance

Historical Comparison
KTTA
HUIZ

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: